Dermoscopy

Participants will learn to differentiate benign nevi from early acral melanoma, identify high-risk features requiring biopsy or referral, and recognize mimickers such as hemorrhage or traumatic pigmentation. Case-based questions and evidence-based insights will guide learners toward improved diagnostic confidence and patient outcomes in both primary and specialty care settings.

There is no commercial support for this activity. 

Target Audience

This activity is designed for an audience of Physicians, Nurses, Nurse Practitioners, and Physician Assistants.

 


 

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Differentiate the dermoscopic patterns characteristic of benign versus malignant lesions on volar and acral skin.
  • Recognize the significance of the parallel ridge pattern as a hallmark feature of acral melanoma.
  • Identify the typical presentations of benign acral nevi, including the parallel furrow and fibrillar patterns.
  • Distinguish acral hemorrhage from melanocytic lesions using dermoscopic clues such as color, border, and pattern.
  • Describe the dermoscopic features associated with congenital volar nevi and the "peas in a pod" pattern.

 

Course summary
Available credit: 
  • 7.50 AANP
  • 7.50 AAPA Category 1 CME
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 ANCC
Course opens: 
03/27/2025
Course expires: 
03/27/2026
Cost:
$0.00
Rating: 
0
Date in City, State
United States


 

DISCLOSURES

Name

Relationship

Commercial Interest

Richard Usatine, MD (faculty)

N/A

Nothing to disclose

Tracey Vlahovic, DPM (faculty)

Advisor

Ortho Dermatologics

Risha Bellomo, PA(faculty/planner)

N/A

Nothing to disclose

Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations

N/A

Nothing to disclose

Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer)

N/A

Nothing to disclose

Michele Bielarski, RN (planner/reviewer)

N/A

Nothing to disclose

AKH Inc Staff and Planners

N/A

Nothing to disclose

BCI Management and Communication Staff and Planners

N/A

Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.




 

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

 

Disclosure of Unlabeled Use and Investigational Product 

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Disclaimer 

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.


 

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and BCI Management and Communications. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 7.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Credit being awarded: 7.50 ANCC contact hours

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.50 AAPA Category 1 CME credits. Approval is valid until 03/27/2026. PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 7.50 contact hours.

 

Available Credit

  • 7.50 AANP
  • 7.50 AAPA Category 1 CME
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 ANCC

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Participants will learn to differentiate benign nevi from early acral melanoma, identify high-risk features requiring biopsy or referral, and recognize mimickers such as hemorrhage or traumatic pigmentation. Case-based questions and evidence-based insights will guide learners toward improved diagnostic confidence and patient outcomes in both primary and specialty care settings.